The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products
Active Pharmaceutical Ingredients
The initiative leverages chemical production facilities at the company’s Visp (Switzerland) site to address increasing global early-intermediates supply security and quality concerns.
European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry.
Olon, an API contract development and manufacturing organization and generics supplier, announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India.
The NUVISAN GROUP signed an agreement with NESTLÉ SKIN HEALTH/ GALDERMA to take over parts of the R&D capacities in Sophia-Antipolis (France).
KBI Biopharma announced that its subsidiary KBI Biopharma BVBA has begun operations at its newly completed laboratories in Leuven, Belgium.
Nemus Bioscience announced an agreement with AMRI for the development and manufacture of Nemus’ proprietary cannabinoid-based active pharmaceutical ingredients (API).